BLUEBIRD STRATEGIES

Lobbying for CELLTRION USA, INC. · Biopharmaceutical Company

Filing 4th Quarter - Report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 21, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Client based in

New Jersey

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 1

Health Issues

Issues related to drug pricing, FDA drug regulations

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.